The Korea Herald

ADB Ventures participates in switchgear company nuventura's second closing of seed funding round

Apr 12, 2022

Nuventura aims to help reduce the use of the highly potent greenhouse gas, SF6, amid global growth and the continued acceleration of climate action. SINGAPORE, April 12, 2022 /PRNewswire/ -- Nuventura, the Berlin-based developer of switchgear technologies that help eliminate Sulphur Hexafluoride (SF6) – the world's strongest greenhouse gas – is pleased to reveal that ADB Ventures (the Asian Development Bank's venture arm) participated in a second closing o
Strong Growth in Digital Health Powers MediHeroes, A Cross Border B2B Medical Platform

Apr 12, 2022

SINGAPORE, April 12, 2022 /PRNewswire/ -- MediHeroes will launch a "Verify Before Buy" platform created especially for suppliers, buyers and service providers in the MedTech industry on April 15, 2022. A transformative industry platform, MediHeroes helps buyers and sellers save months to years of time, with credentials validations and go-to-market services. Strong Growth in Digital Health Powers MediHeroes, A Cross Border B2B Medical Platform Asia is increasingly be
Crypto Derivatives Platform Overbit Launches MetaTrader 5 (MT5) For Faster Crypto And Forex Trading

Apr 12, 2022

SINGAPORE, April 12, 2022 /PRNewswire/ -- Leading Bitcoin derivatives trading platform, Overbit, announced the launch of MetaTrader 5 (MT5) to enhance a faster and seamless on-the-go trading experience for its traders. Overbit is one of the first leading crypto derivatives companies who are offering an upgrade on its exchange with the integration of MT5. This new platform is now available through desktop and mobile applications. Overbit CEO, Chieh Liu said, "MetaTrader 5 (MT5) is i
VIENNA COFFEEHOUSE BRAND, JULIUS MEINL, FUELS MEANINGFUL MOMENTS WITH 'SAY THANK YOU' INITIATIVE

Apr 12, 2022

VIENNA, April 12, 2022 /PRNewswire/ --Inviting someone for a coffee or smiling at a stranger could inspire thousands more acts of kindness, according to Julius Meinl – one of Europe's oldest coffee brands. Julius Meinl fuels meaningful moments with ‘Say Thank You’ initiative To mark its 160th anniversary, Julius Meinl is lifting the lid on simple acts of gratitude with a new study into everyday moments that mean the most. 4,000 adults were polled, with responses highlighti
Angel Yeast's New Food Ingredients Smart Factory Enters Operation

Apr 11, 2022

YICHANG, China, April 11, 2022 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast" or "the Company", 600298.SH), a listed global yeast and yeast extract manufacturer, is opening a new factory of food ingredients. The factory – loaded with state-of-the-art facilities that enable automated operation and heightened quality control – offers enhanced productivity, and higher energy efficiency, with the first batch of products having rolled off its smart mixed production line.
Need Help Removing Stubborn Malware Other Antivirus Apps Don't Fix? SpyHunter 5's HelpDesk Generates Custom Malware Fixes for You

Apr 11, 2022

DUBLIN, April 11, 2022 /PRNewswire/ -- EnigmaSoft Limited's SpyHunter 5 includes the HelpDesk – a one-on-one personalized technical support service. Sometimes users encounter unique problems related to stubborn malware infections that traditional anti-malware software may not fully detect or remove. SpyHunter 5's HelpDesk connects users directly to our SpyHunter 5 technicians who can create custom malware fixes to address unique malware issues where needed. SpyHunter 5's HelpDesk is
/DISREGARD RELEASE: HanAll Biopharma and Daewoong Pharmaceutical/

Apr 11, 2022

We are advised by HanAll Biopharma and Daewoong Pharmaceutical that journalists and other readers should disregard the news release, "Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative", issued 11-Apr-2022 over PR Newswire.
PharmAbcine Presents Updated Preclinical Data of Its Anti-VISTA Antibody Candidate at AACR 2022

Apr 11, 2022

DAEJEON, South Korea, April 11, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the Company presented an updated preclinical data PMC-309, the Company's anti-VISTA antibody candidate at AACR (American Association for Cancer Research) 2022 Annual Meeting currently taking place both online and offline in New Orleans. PMC-309, one of the company's first
Ping An Releases 2021 Sustainability Report

Apr 11, 2022

HONG KONG and SHANGHAI, April 11, 2022 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEx:2318; SSE:601318) has published its 2021 Sustainability Report. The sustainability report, the 13th from Ping An, highlights the Group's achievements in sustainability strategy, management, and operations as well as its milestones in environmental, social and governance performance. Advancing green fi
TRAVELX AND AIR EUROPA LAUNCH WORLD'S FIRST NFT FLIGHT

Apr 11, 2022

Designed in partnership with group of world-renowned artists, "NFTickets" will give access to a business class seat on a Miami-bound flight this November MIAMI, April 11, 2022 /PRNewswire/ -- TravelX, the company building the travel industry's first blockchain-based distribution protocol, today announced that it has joined forces with Air Europa, the third-largest Spanish airline flying to over 60 destinations around the world, to release the world's first NFT (non-fungible toke
Global pharma organizations back Turn Biotechnologies to advance its cell rejuvenation program

Apr 11, 2022

Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas MOUNTAIN VIEW, Calif., April 11, 2022 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that it closed an oversubscribed fundraising round to support the next stage of its development. Inves
APRINOIA Therapeutics received FDA clearance to initiate APNmAb005 Phase 1 clinical trial

Apr 11, 2022

BOSTON, April 11, 2022 /PRNewswire/ -- APRINOIA Therapeutics announces today that the U.S. Food and Drug Administration (FDA) has granted a may proceed authorization for its novel therapeutic anti-tau monoclonal antibody, APNmAb005, allowing the company to test and evaluate its safety in healthy subjects in a phase 1 single ascending dose study. APNmAb005 is a unique antibody that recognizes a conformation-dependent epitope present only in pathological forms of tau proteins. It preferentially
Singapore-based women's healthcare company marks its first Financial Times ranking

Apr 11, 2022

Making its debut on the fourth annual Financial Times ranking of 500 of Asia-Pacific's high-growth companies, INEX Innovate - the pioneering healthcare technology company targeting women's health - is one of only 20 healthcare companies listed in the prestigious line up. SINGAPORE, April 11, 2022 /PRNewswire/ -- Emerging from the National University of Singapore (NUS), INEX Innovate is a Singapore-based molecular diagnostics developer and medical laboratory operator.
ExxonMobil Introduces New Exceed™ S Performance Polyethylene, Enabling Converters to Rethink Film Design for Simpler Solutions

Apr 11, 2022

SPRING, Texas, April 11, 2022 /PRNewswire/ -- ExxonMobil introduced today its new Exceed™ S performance polyethylene (PE) resins, which deliver industry-leading combinations of stiffness and toughness while being easy to process. Utilizing the company's latest innovations in polymer science, the new PE platform provides opportunities to reduce the complexity of film formulations and designs while improving film performance, conversion efficiency, and packaging durability versus current m
Levi Strauss & Co. accelerates sustainable growth with aggressive expansion strategy

Apr 11, 2022

East Asia Pacific to reinvent, refresh and open new stores at more than 100 locations SINGAPORE, April 11, 2022 /PRNewswire/ -- Levi Strauss & Co. (NYSE: LEVI) today announced ambitious plans to accelerate sustainable business growth and drive commercial success in the East Asia Pacific (EAP) region. Central to the growth strategy is the diversification of the business across geographies, apparel categories and distribution channels. Levi Strauss & Co. will be launching new s